The Tumor Marker Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Tumor Marker Testing Market?
The market size of tumor marker testing has significantly expanded in the past few years. It is projected to increase from $17.18 billion in 2024 to $18.6 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Tumor Marker Testing Industry?
The Tumor Marker Testing Global Market is predicted to rise to a value of $25.27 billion in 2029, with a compound annual growth rate (CAGR) of 8.0%.
Download Your Free Sample of the 2025 Tumor Marker Testing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Tumor Marker Testing Market?
The key drivers in the tumor marker testing market are:
• Growing awareness of early cancer detection
• Increased funding for cancer research
• Expansion of personalized medicine field
• Improved insurance coverage and healthcare expenditure
Global Market Segmentation: Identifying Major Tumor Marker Testing Industry Segments
The tumor marker testing market covered in this report is segmented –
1) By Product: Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains, Other Products
2) By Methods: Screening, Imaging, Theranostics, Sigmoidoscopy, Other Methods
3) By Application: Hospitals, Commercial Or Private Laboratories, Physician Offices Or Group Practices, Cancer Clinics, Ambulatory Care Centers
Subsegments:
1) By Biochemical Markers: Alpha-fetoprotein (AFP), Prostate-Specific Antigen (PSA), Carcinoembryonic Antigen (CEA), Cancer Antigen 125 (CA 125), Cancer Antigen 19-9 (CA 19-9), Human Chorionic Gonadotropin (hCG)
2) By Oncogenes: HER2/neu, KRAS, BRAF, EGFR (Epidermal Growth Factor Receptor), c-MYC, p53
3) By Growth Factors: Vascular Endothelial Growth Factor (VEGF), Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-beta (TGF-ß), Fibroblast Growth Factor (FGF), Insulin-like Growth Factor (IGF)
4) By Hormones: Estrogen Receptors (ER), Progesterone Receptors (PR), Thyroglobulin, Calcitonin, Adrenocorticotropic Hormone (ACTH), Gastrin
5) By Colony Stimulating Factors: Granulocyte Colony-Stimulating Factor (G-CSF), Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), Macrophage Colony-Stimulating Factor (M-CSF)
6) By Lymphokines: Interleukin-2 (IL-2), Interferon-gamma (IFN-?), Tumor Necrosis Factor-alpha (TNF-a), Interleukin-6 (IL-6)
Pre-order the 2025 Tumor Marker Testing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Tumor Marker Testing Market?
The key trends in the tumor marker testing market are:
• Technological advancements are a key trend shaping the future of the market.
• Product innovation plays a significant role in the development of the market.
• Advancements in diagnostic technologies are greatly transforming the market.
• Increasing strategic collaborations is an emerging trend in the market.
Who Are the Top Competitors & Leading Players in the Tumor Marker Testing Market?
Major players in the tumor marker testing market are:
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• F. Hoffmann-La Roche AG
• Danaher Corporation
• Siemens Healthineers AG
• Becton Dickinson and Company (BD)
• Quest Diagnostics Inc.
• Agilent Technologies Inc
• Hologic Inc.
• Illumina Inc.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• DiaSorin S.p.A.
• Myriad Genetics
• Ortho Clinical Diagnostics PLC
• Veracyte Inc.
• Biodesix Inc.
• Biocept Inc.
• Proteomedix AG
• OncoCyte Corporation
• Biocartis NV
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the tumor marker testing market in 2024
